Correspondence should be addressed to J.P.L. (jianping.lu@hrcc.on.ca) and J.H.P. (Jehonathan.Pinthus@hrcc.on.ca), telephone 001-905-387-9711 extension 67120. ABSTRACT Identification of novel protein interactions and their mediators is fundamental in understanding cellular processes and is necessary for protein-targeted therapy. Evidently high throughput formatting of these applications in living cells would be beneficial, however no adequate system exists. We present a novel platform technology for the high throughput screening and verification of protein interactions in living cells. The platform's series of Dual Expression Recombinase Based (DERB) destiny vectors individually encode two sets of recombinase recognizable sequences for inserting the protein open reading frame (ORF) of interest, two sets of promoters and reporter tags in frame with the ORFs for detecting interactions. Introduction into living cells (prokaryotic and eukaryotic) enables the detection of protein interactions by fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC). The DERB platform shows advantages over current commercialized systems by DERB vectors validated through proof-of-principle experiments and the identification of an unknown interaction.
INTRODUCTION
The completion of the human genome sequencing project has presented the opportunity and challenge of identifying a staggering number of gene products, proteins, their interactions and modifiers. In addition to the 35,000 predicted proteins in the human genome, mutation and alternative splicing contribute further to this astounding number and to the quantity of possible cellular interactions 1 . Accordingly, the targeted therapy of a single protein can affect processes outside of the original intent which would be avoided with the introduction of a large-scale pre-screening system to identify interaction partners. The integration of a technical development into protein therapy will provide significant improvements to current research methods and aid in the prevention and treatment of disease 2, 3 .
The most familiar method for screening protein interactions in/ex vivo is the yeast two-hybrid assay. It is prevalent despite its complicated, time consuming protocol and requirement for the results to be confirmed in additional living cell systems 4 . Alternative in/ex vivo approaches include FRET [5] [6] [7] and BiFC 8, 9 , however the plasmids for analysis require individual construction which reduces the screening efficiency [5] [6] [7] [8] [9] [10] . Integration of these approaches into efficient high throughput detection has thus far not been successful.
In order to overcome these limitations, we have developed a platform that supports high throughput screening
and verification of protein interactions in living cells. We have engineered a DERB (Dual Expression Recombinase Based) vector platform to facilitate highly efficient cloning/subcloning of potential interaction partners into a final expression vector. The DERB vectors encode the sequences of two separate sets of promoters, reporter tags for FRET or BiFC detection, and recombinase recognizable sites for the insertion of ORF of the proteins of interest and selection securities for efficient cloning. Introducing a protein couplet into a single destiny vector through two-step recombination eliminates the requirements of multiple step restriction-purification-ligation subcloning and co-transfection. Additionally, introducing the vectors into living cells, both prokaryotic and eukaryotic, enables the examination of the proteins of interest utilizing generic laboratory equipment including but not limited to the plate reader, flow cytometer, fluorescent microscope and/or confocal microscope.
To appreciate the potential of the DERB platform and demonstrate its relevance in hypothesis-driven research we applied it to detect protein interactions in the adiponectin signaling pathway. This signal transduction pathway consisting of recently identified receptors and down stream constituents is becoming an important area of research and development due to its role in public health issues including diabetes mellitus 11 , obesity and cancer 12, 13 . However, limited knowledge of the adiponectin receptor interaction partners restricts the development of therapeutic reagents for relief from the associated diseases. The identification of a novel receptor interaction in the pathway is attributed to the DERB technology. The potential of this method extends to include the automated ex vivo screening of therapeutics to modulate essential interactions, such as the adiponectin receptor interaction identified. The platform ultimately supplies an innovative method for the screening and confirmation of protein interactions in living cells, which can be effectively integrated into a high throughput configuration facilitating the process of screening for modulators that regulate protein-protein interactions.
RESULTS

Efficient integration of desired protein ORFs
The proteins of interest present in individual donor vectors were sequentially introduced into the recombinase recognizable loci of a DERB destiny vector ( Fig. 1ai) . Two independent recombination reactions brought the destiny vector to its dual protein expression vector formation and enabled protein interaction detection through contributed to the negative interaction controls. Vimentin is well known to form polymers while there is no direct interaction between vimentin and tubulin structure 14 . Consideration of the differences in post-translational modification between prokaryotic and eukaryotic cells prompted twin line analysis of the platform and was mediated through the derivatives and associated controls aforementioned. Plate reader examination established a p-ECFP-EYFP background fluorescence level below the p-ECFPEYFP fusion
FRET intensity (FRETN). Constructs p-ECFPAPPL1-EYFPADIPOR1 and p-ECFPAPPL1-EYFPADIPOR2
displayed positive interaction FRETN mirroring the fusion value ( Fig. 2a) . Ultimately every control in the system whether expressed in a prokaryotic or eukaryotic line attained parallel FRETN behavior, enabling examination in either cell line. Confocal microscope examination of pFer-ECFPAPPL1-EYFPADIPOR1 and pFer-ECFPAPPL1-EYFPADIPOR2 further validated results ( Fig. 2b) . 
BiFC protein interaction detection
An alternative destiny vector lineage was engineered to integrate two proteins of interest through the aforementioned two-step recombination and translate the proteins fused to divisions of EYFP. The C-terminal (Yc) and N-terminal (Yn) parts generated no fluorescence individually however fluoresced when brought into close proximity of each other, and thus its fusion with interacting proteins generated fluorescence 8, 9 . HeLa 
Protein interaction analysis validated with immunoprecipitation
Destiny vector pFer-ECFPAPPL1-EYFPADIPOR1 HeLa cell lysate was incubated with anti-ADIPOR1 followed by protein G beads to form bead-anti-ADIPOR1-ADIPOR1 complexes. Collection of the complexes and proteins associated to ADIPOR1 were western blotted with anti-APPL1 and HRP conjugated secondary antibody. Bands revealed APPL1 presence within the ADIPOR1 collection and confirmed interaction (Fig. 4) . (Fig. 5a) . Investigation of pFer-YcADIPOR1-YnADIPOR1 with a 96-well plate reader and flow cytometer confirmed results identified with the FRET prokaryotic construct (Fig. 5b) . Further affirmation of the protein interaction through fluorescent microscopy with the pFer-YcADIPOR1-YnADIPOR1 expression vector supported all previous results. Validity was furthered through the western blotting of the pFer-YcADIPOR1-YnADIPOR1 construct which revealed unbiased detection and the conclusion of the ADIPOR1-ADIPOR1interaction (Fig. 5c ). 
DISCUSSION
Modern research in the field of protein interactions in living cells is restricted in practice by the limited number of known proteins and/or interaction partners [15] [16] [17] . Consequently, there is an emerging demand for the high throughput screening (HTS) of protein interactions and modifiers to ultimately benefit the development of protein-based therapeutics with minimal side effects 18 . HTS integration of this procedure into living cells is dependent upon the degree of automation at two fundamental stages; the cloning/subcloning of protein ORFs and detection of protein interactions.
Our DERB platform provides an efficient subcloning approach for the HTS and verification of novel protein to prevent its growth in E. coli DH5α (Fig. 1aii) . Subsequent CRE mediated recombination introduces ORF2-CmR into a DERB single expression vector forming a dual expressing vector, which renders its resistance to chloramphenicol and sucrose. The donor vector sensitivity to sucrose (SucB) and the single expression DERB vector deficient of CmR gene collectively prevent the proliferation of clones with unsuccessful recombination plasmids (Fig. 1aiii) . The aforementioned selection strategy provides highly efficient dual expression vector generation with rare exceptions, thus rendering extensive clone selection from those generated as a redundant practice (See Supplementary: DERB Selection Strategy for details). That, coupled to the ability of immediate introduction into prokaryotic or eukaryotic cells, demonstrates the capability and efficiency of the platform for enabling high throughput formatting of protein interaction examination.
Translating the proteins of interest fused to either the ECFP EYFP or Yc Yn set of fluorescent tags provides a direct path for the FRET or BiFC detection of protein interactions. Expression of the ORF partners is controlled by the dual presence of an identical (pT7, CMV) or similar (modified FerH, FerL) promoter, which is responsible for the induction of both fusion proteins, and ensures their simultaneous expression at substantial levels (Fig. 5c) . The well cited FRET donor-sensitized acceptor fluorescence three-channel method 19, 20 for the detection of protein interactions enables the use of numerous generic analyzers thus increasing the accessibility of the DERB technology. In the conformational experiments utilizing confocal microscopy, images of the controls and experimental groups were acquired with an identical laser intensity and PMT value. FRETN was obtained through the equation of Xia 21, 22 which provided measurements with a standard error of less than 7% 19 . Though confocal microscope analysis is reliable for FRETN measurement, it is difficult to be integrated into a high throughput protocol. As such, it is best to utilize confocal microscopy as is essential in many illnesses including diabetes, obesity and cancer, which are important public health issues.
The interaction between adiponectin receptor 1 is likely significant to the activation and subsequent signal transduction as dimerization or polymerization of receptors is well known to be important for signaling functions 24 . Our platform provides a simple tool for the screening and verification of receptor interaction partners.
A possible concern regarding the workability of the destiny vectors relates to their large size 25 . It has been reported that about 300kb of an insert sequence can be cloned or subcloned into common vectors 26 Table 1) and eukaryotic (Supplementary Table 2 ) cells whereas BiFC destiny vectors with the Yc Yn tag set were introduced into eukaryotic cells (Supplementary Table 3 ). The sources of other entry vector or other vectors with the ORF of interest used are listed in Supplementary Table 4 . Methods 3 for MIMX information (The minimum information required for reporting a molecular interaction experiment) 28 .
